Current status of valvular heart disease in China_West China Medical Journal

Authors：

 GAO Runlin

National Center for Cardiovascular Disease; Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, P. R. China;

Corresponding author：

GAO Runlin, Email: gaorunlin@citmd.com

Keywords：

Valvular heart disease; Transcatheter aortic valve replacement; Aortic stenosis

DOI：

10.7507/1002-0179.201712108

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Valvular heart disease (VHD) is a common cardiac disease. Patients with severe VHD have a poor prognosis. With the development of minimal invasive treatments in VHD, especially with the wide application of transcatheter aortic valve replacement in aortic stenosis, these diseases have been regained attention. The disease spectrum and modes of treatment have also changed. However, we currently lack a large population-based VHD-related epidemiologic study in China. In this article, we will summarize the current status of VHD in China using available epidemiologic data.

Citation： GAO Runlin. Current status of valvular heart disease in China. West China Medical Journal, 2018, 33(2): 127-131. doi: 10.7507/1002-0179.201712108 Copy

1.	Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet, 2006, 368(9540): 1005-1011.
2.	Hu P, Liu XB, Liang J, et al. A hospital-based survey of patients with severe valvular heart disease in China. Int J Cardiol, 2017, 231(231): 244-247.
3.	Pan WZ, Zhou DX, Cheng L, et al. Candidates for transcatheter aortic valve implantation may be fewer in China. Int J Cardiol, 2013, 168(5): E133-E134.
4.	Iung B, Vahanian A. Epidemiology of acquired valvular heart disease. Can J Cardiol, 2014, 30(9): 962-970.
5.	Hwang W, Ch'en TC, Hsu HF, et al. Rheumatic valvular disease of adults in North China. Chin Med J, 1957, 75(7): 544-567.
6.	Liu FZ, Xue YM, Liao HT, et al. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China. J Thorac Dis, 2014, 6(12): 1724-1730.
7.	Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J, 2003, 24(13): 1231-1243.
8.	Jilaihawi H, Wu Y, Yang Y, et al. Morphological characteristics of severe aortic stenosis in China: imaging corelab observations from the first Chinese transcatheter aortic valve trial. Catheter Cardiovasc Interv, 2015, 85(Suppl 1): 752-761.
9.	Kong WKF, Regeer MV, Poh KK, et al. Inter-ethnic differences in valve morphology, valvular dysfunction, and aortopathy between Asian and European patients with bicuspid aortic valve. Eur Heart J, 2017. doi: 10.1093/eurheartj/ehx562.
10.	顾恺时. 胸心外科手术学. 北京: 人民卫生出版社, 1985: 5-6.
11.	国家心血管病中心. 中国心血管病报告 2016. 北京: 中国大百科全书出版社, 2016: 167-168.
12.	陈传荣, 陈记言, 胡世舞, 等. 经皮穿刺气囊二尖瓣成形术. 中华心血管病杂志, 1986, 14(6): 321.
13.	Song GY, Jilaihawi H, Wang M, et al. Severe symptomatic bicuspid and tricuspid aortic stenosis in China: characteristics and outcomes of transcatheter aortic valve replacement with the Venus-A valve. Structure Heart, 2017. doi.org/10.1080/24748706.2017.1398437.
14.	王建安, 刘先宝. 经导管心脏瓣膜疾病介入治疗进展及中国发展现状. 中国医学前沿杂志: 电子版, 2015, 7(1): 21-25.
15.	Feng Y, Zhao ZG, Baccaro J, et al. First-in-man implantation of a pre-packaged self-expandable dry-tissue transcatheter aortic valve. Eur Heart J, 2017. doi: 10.1093/eurheartj/ehx587.

1. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet, 2006, 368(9540): 1005-1011.
2. Hu P, Liu XB, Liang J, et al. A hospital-based survey of patients with severe valvular heart disease in China. Int J Cardiol, 2017, 231(231): 244-247.
3. Pan WZ, Zhou DX, Cheng L, et al. Candidates for transcatheter aortic valve implantation may be fewer in China. Int J Cardiol, 2013, 168(5): E133-E134.
4. Iung B, Vahanian A. Epidemiology of acquired valvular heart disease. Can J Cardiol, 2014, 30(9): 962-970.
5. Hwang W, Ch'en TC, Hsu HF, et al. Rheumatic valvular disease of adults in North China. Chin Med J, 1957, 75(7): 544-567.
6. Liu FZ, Xue YM, Liao HT, et al. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China. J Thorac Dis, 2014, 6(12): 1724-1730.
7. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J, 2003, 24(13): 1231-1243.
8. Jilaihawi H, Wu Y, Yang Y, et al. Morphological characteristics of severe aortic stenosis in China: imaging corelab observations from the first Chinese transcatheter aortic valve trial. Catheter Cardiovasc Interv, 2015, 85(Suppl 1): 752-761.
9. Kong WKF, Regeer MV, Poh KK, et al. Inter-ethnic differences in valve morphology, valvular dysfunction, and aortopathy between Asian and European patients with bicuspid aortic valve. Eur Heart J, 2017. doi: 10.1093/eurheartj/ehx562.
10. 顾恺时. 胸心外科手术学. 北京: 人民卫生出版社, 1985: 5-6.
11. 国家心血管病中心. 中国心血管病报告 2016. 北京: 中国大百科全书出版社, 2016: 167-168.
12. 陈传荣, 陈记言, 胡世舞, 等. 经皮穿刺气囊二尖瓣成形术. 中华心血管病杂志, 1986, 14(6): 321.
13. Song GY, Jilaihawi H, Wang M, et al. Severe symptomatic bicuspid and tricuspid aortic stenosis in China: characteristics and outcomes of transcatheter aortic valve replacement with the Venus-A valve. Structure Heart, 2017. doi.org/10.1080/24748706.2017.1398437.
14. 王建安, 刘先宝. 经导管心脏瓣膜疾病介入治疗进展及中国发展现状. 中国医学前沿杂志: 电子版, 2015, 7(1): 21-25.
15. Feng Y, Zhao ZG, Baccaro J, et al. First-in-man implantation of a pre-packaged self-expandable dry-tissue transcatheter aortic valve. Eur Heart J, 2017. doi: 10.1093/eurheartj/ehx587.

Next Article
The current situation of transcatheter aortic valve replacement in China 2017

West China Medical Journal

Current status of valvular heart disease in China

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content